Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.1.111NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.619NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
C.36.3.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
C.36.3NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
A.23.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.316NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
AZ.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.436NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.558NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.518NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.368NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.404NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.306NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.328NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
A.2NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.533NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
AY.120.2 (Delta)NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.528NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
C.1.2NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
AY.91 (Delta)NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.3NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.39NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.617NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.383NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.40NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
AY.95 (Delta)NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.189NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BA.1.13NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
C.13NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
C.4NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.545NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.482NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
HK.3.5NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
GY.1.1.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
HK.3.11NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
JC.4NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.564NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.461NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.486NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.3NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.603NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.70NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.606NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.601NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.186NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.324NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.322NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.160.23NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.416NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.239NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used